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Abstract 
It is widely argued that the final decades of the twentieth century saw a fundamental change, 
marked by terms such as biomedicalization and geneticization, within the biomedical sciences. 
What unites these concepts is the assertion that a vast array of emerging technologies²²in 
genomics, bioengineering, information technology, and so forth²²are transforming 
understandings of disease, diagnosis, therapeutics, and working practices. While clearly important, 
these analyses have been accused of perpetuating theoretical trends that attribute primacy to the 
new over the old, discontinuity over continuity, and the laboratory over the field. In this paper I 
show that in the case of autism the effects of genomic technologies can only be understood by 
simultaneously examining the role of questionnaires. Due to shortcomings in clinical diagnoses, 
genomic analyses could only progress once questionnaires had been developed to address a 
´UHYHUVHVDOLHQWµZLWKLQWKH´WHFKQRORJLFDOV\VWHPµ)XUWKHUPRUH,DUJXHWKDWTXHVWLRQQDLUHVVXFK
as the Autism Quotient have a significance that surpasses the genomic classifications they were 
designed to undergird. I argue that to neglect the role of mundane technologies such as 
questionnaires in contemporary biomedicine is to miss complexity, bifurcate old and new, and do 
a disservice to innovation. 
  
Introduction 
It is widely argued that the final decades of the twentieth century saw something of a paradigm shift in the 
biomedical sciences²²a biomedicalization and molecularization that ushered in a new ´regime of truthµ 
(Clarke et al. 2003: 163) or ´politics of lifeµ (Rose 2001; Rose 2007). This new vision claimed that 
technological advances would facilitate a comprehension RIOLIH·VFRGHIURPWKHJHQRPHXS, and lead to 
significant new understandings of both health and illness. And while the results of the Human Genome 
Project gave pause for thought, the story goes, this process continues more or less unabated. 
In focusing upon autism here, I am not contesting the described dominance of biomedicine: In the UK, 
the majority of research funding goes on understanding the biology of autism, a finding mirrored²²albeit 
to a lesser extent²²in the United States (Pellicano et al. 2013: 22; Singh et al. 2009). Similarly, the majority 
of both scientists (Decoteau & Underman 2015) and parents (Silverman 2008; Singh 2014) appear to 
understand autism as a genetic, often heritable condition. These findings alone lead to the conclusion that 
autism has undergone a process of ´geneticizationµ (Bumiller 2009; Navon & Eyal 2014; Navon & Eyal 
2016), at least in the ´stripped downµ sense offered by Hedgecoe (2001: 876) and quite possibly in the 
broader sense articulated by Lippman (Lippman 1992).1 Nonetheless, I am uncomfortable with the above 
descriptions in relation to autism. Revolving as they do around novel and emerging biotechnologies, the 
terms are suggestive of a sharp break, or epistemic shift, away from ´clinicalµ gazes and ´traditionalµ 
technologies. Accordingly, they risk perpetuating trends in science and technology studies (STS) and 
medical sociology that have long been critiqued for attributing a primacy to the new over the old, 
discontinuity over continuity, and the laboratory over the field (Edgerton 2008; Kerr 2004); ´blinded by 
novelty,µ as Raman and Tutton succinctly put it (Raman & Tutton 2010: 729). 
Here, then, I seek to trouble existing accounts of emerging biotechnology in autism, a condition that in 
many senses typifies and thus speaks to broader processes of geneticization. Drawing upon a wide range of 
published sources, I argue that molecular genetics and genomics do indeed play a crucial role in 
                                                          
1 +HGJHFRH·V´stripped downµ definition suggests ´that in medicine, geneticization takes place when a condition is 
linked to a specific stretch of DNAµ (Hedgecoe 2001: 876). Lippman is not restricted to changes ´in medicineµ and 
FRQVLGHUVIRULQVWDQFHFKDQJHVLQWKHRQWRORJ\RIWKHVHOI$V:HLQHU·VZRUNKDVUHSHDWHGO\VKRZQ (e.g. Weiner et al., 
2017), the sociological reality of these two processes is largely separable. 
contemporary understandings of autism. However, this role can only be understood by considering a 
significant number RIPXQGDQH´FODVVLFDOµ methods that are diffracted through emerging biotechnologies. 
In the case of autism, the classical methods of greatest note are a number of questionnaires²²the Autism 
Quotient, the Broader Autism Phenotype Questionnaire, and the Social Responsiveness Scale, amongst 
others²²created at the turn of the twenty-first century LQRUGHUWRDGGUHVVD´UHYHUVHVDOLHQWµ+XJKHV
in large technological systems oriented towards a genomic understanding of autism. Furthermore, I argue 
that the cultural and scientific significance of these questionnaires surpasses the genomic classification they 
were devised to undergird; by virtue of their simplicity and mobility these questionnaires have been utilized 
in a range of contexts²²both inside and outside of scientific institutions²²with a wide range of 
consequences.  
That the social science literature focuses upon emerging genomic technologies, to the exclusion of the pen 
and paper innovations examined here, ensures that theses considering the geneticization of autism 
simultaneously over- and under-play the importance of genetics. They overplay the role of emerging 
technologies by failing to grasp that changes are better understood as part of larger system that cannot be 
radically disconnected from the past. They concurrently underplay the role of these biotechnologies by failing 
to see their influence in diverse, mundane settings often far removed from the site of origin. In making this 
argument, I do not deny the importance of genetics or genomics in general or in relation to autism. Rather, 
I suggest that arguments that claim that autism has been straightforwardly biologized, medicalized, or 
geneticized miss a great deal of complexity and bifurcate old and new concepts and technologies, doing a 
disservice to innovation (Edgerton 2008: xiv) and failing to see the influence of this technological system 
in diverse settings that are often far removed from genetically oriented clinical or laboratory settings. 
Autism and genetics 
It would be wrong to say that a genetic autism is an axiom as has been argued, for example, to be the case 
with schizophrenia (Hedgecoe 2001: 880). From its discovery in the 1940s through until at least the 1960s 
autism was primarily understood as an acquired condition caused by maternal deprivation (Evans 2013: 9; 
Silverman 2012: 61-92) and numerous groups continue to dispute a genetic ontology (Decoteau & 
Underman 2015; Hobson-West 2007) 1RQHWKHOHVV SHUKDSV WKH PRVW VWULNLQJ WKLQJ DERXW DXWLVP·V
´geneticizationµ is just how typical the process has been. Since the 1960s autism has been described in 
genetic terms (Silverman 2012: 144; Singh 2016: 86) and, as has been widely discussed within the social 
science literature (Evans 2013; Eyal et al. 2010: 14; Feinstein 2010: 140; Silberman 2015: 346; Silverman 
2012: 146; Singh 2016: 86), genetic research has played an increasingly important role since the 1970s when 
twin studies, most notably that conducted by Susan Folstein and Michael Rutter in 1977, showed that 
monozygotic twins have incredibly high levels of concordance for autism symptomology.   
It seems unlikely that any scientist ever thought it would be quite as simple as locating an ´autism gene,µ 
for researchers from various disciplines had been proposing a genetically heterogeneous condition since at 
least the late 1970s (e.g., Freeman 1977: 143). Nonetheless, it was still hoped that the insights from the 
Human Genome Project would locate the genetic underpinnings of autism. However, and as Rose has 
phrased it more generally, this vision of the grail ´proved to be as ephemeral as most such visionsµ (Rose 
2007: 46) with a widespread failure to replicate findings (see Vorstman et al. (2017) for an overview of 
contemporary autism genetics). It has been widely argued that, following these failures, autism researchers 
changed tack and began to turn away from genetics and towards genomics. As Singh has phrased it, instead 
of operating under ´the assumption that autism is a result of a major heritable gene,µ this ´emergent way 
of scientifically viewing and practicing autism implicates hundreds of genes interacting with one another at 
the molecular levelµ (Singh 2016: 83). The attempt to explicate autism in genomic terms can be understood 
DVD´FRPPRQV\VWHPJRDOµ+XJKHVIRUDJUHDWGHDORIFRQWHPSRUDU\UHVHDUFKLQWRWKHFRQGLWLRQ 
and, as we know, autism is pretty well typical in this regard (Mitchell & Waldby 2010). 
This shift from genetics to genomics has, again, been understood by some as a paradigmatic or epistemic 
shift; evidence of an emergent genomic style of thought or genomic gaze (Bliss 2015; Rose & Abi-Rached 
2013: 44; Singh 2016). It is argued that this shift has profound implications for autism, with new ´trading 
zonesµ emerging that connect previously diverse groups of patients (Navon & Eyal 2014) and facilitate 
diagnostic expansion (Navon & Eyal 2016). New and emerging biotechnologies are foregrounded in these 
descriptions²² ´Technologies such as DNA and chromosomal microarrays, next generation sequencing, 
and computer bioinformatics have become essential tools...µ (Singh 2016: 82)²²binding together epistemic 
shifts and novel technologies. 
 Again, these processes are at once specific to autism and typical of geneticization theses. It is perhaps 
unsurprising to note, therefore, that the primacy afforded to emerging biotechnology in relation to autism 
is also found within the broader theoretical literature. &ODUNH·VSLRQHHULQJZRUNRQEiomedicalization²²a 
reference point for much of the autism literature that bears similar traits (e.g. Bumiller 2009; Singh 2016)²
²for example states that: 
Extensive transformations are produced through new diagnostics, treatments, and procedures 
from bioengineering, genomics, proteomics, new computer-based visualization technologies, 
computer-assisted drug developments, evidence-based medicine, telemedicine/telehealth, and so 
on. (Clarke et al. 2003: 162) 
Nikolas Rose, a similarly smoothed touchstone, claims that medicine ´«itself has been transformed. It has 
become technomedicine, highly dependent upon sophisticated diagnostic and therapeutic equipmentµ 
(Rose 2007: 11). What is missed in this foregrounding of biotechnology and transformation, however, is 
WKHIDFWWKDWWKHVH´ KLJKWHFKµDGYDQFHVDUHLQH[WULFDEO\ERXQGZLWKtechnologies that are far more mundane 
and, in many cases, have a much longer history. 
Accounting for the mundane 
Historians of technology remind us that we must not be too hasty to put boundaries around the edges of 
ZKDWFRQVWLWXWHVDQ´HPHUJLQJµWHFKQRORJLFDOV\VWHP(Callon 1981; Hughes 1987) and that attempting to 
understand the influence of emerging technologies without consideration of their mundane and developed 
kin is likely to give a distorted image (Edgerton 2008). Perhaps to a greater extent than allied fields 
(Timmermans & Berg 2003: 104) work within STS has emphasized the importance of mundane 
technologies within society (e.g. Latour 1988; Michael 2000; Pinch 2010; Woolgar & Neyland 2013). 
Nonetheless, and as Michael has noted (2003), analyses rarely place mundane and ´exoticµ technologies 
into conversation with each other.  
Michael (2003) hypothesizes that this lack of conversation between analyses of ´mundaneµ and ´exoticµ 
technologies is as much about academic division of labor as it is the state of the world: Scholars interested 
in ´sober beingµ tend to focus upon mundane technologies, while those interested in ´spectacular 
becomingµ orient towards the exotic (Michael 2003: 128). An erroneous suggestion implicit in this divide, 
0LFKDHO VXJJHVWV LV WKDW PXQGDQH WHFKQRORJLHV OLNH /DWRXU·V GRRU FORVHUV (1988) are involved in the 
reproduction of existing social worlds, while exotic emerging technologies²²like the biotechnologies examined 
here²²are involved in the production of new worlds (Michael 2003).  
The tight binding of the exotic and the productive, I would suggest, is evident in much of the literature 
discussed in previous sections. Despite this, we know that both old and mundane technologies play hugely 
significant roles within both medical (Berg 1996; Berg 1997) and psychiatric (Swallow 2015; Wilson 2014) 
settings. Indeed, we also know that within biomedical settings emerging and mundane technologies actively 
co-constitute each other within large technological systems (Timmermans & Berg 2003: 104).  
The inseparability of emerging and mundane technology, for example, is evident in De&2'(*HQHWLFV·
project in Iceland, one of the most written about enterprises of the genomic era (e.g. Fortun 2008; Pálsson 
& Rabinow 1999). Although rarely emphasized, Ian Hacking argues that what made Iceland uniquely 
attractive for a population mapSLQJSURMHFWOLNH'H&2'(·VZDVQHLWKHUWKHJHQHWLFDOO\KRPRJHQRXVQDWXUH
RIWKHSRSXODWLRQQRUWKDWSRSXODWLRQ·VVWDELOLW\ERWKRIZKLFKZHUHLPSRUWDQWEXWKDUGO\XQLTXH,QVWHDG
LWZDV WKHQDWLRQ·V OLWHUDF\DQG WKHIDFW WKDW LW´KDGQHYHUKDGDPDVVGHVWruction of [written] records... 
JHQHDORJLHVEDFNWRDUHUHOLDEOHµZKLFKPDGHLWVRDSSHDOLQJ(Hacking 2007: 97). Understanding the 
census, the questionnaire, in other words, is crucial to understanding why Iceland became a hub of 
biotechnological research. Indeed, what the literature on biobanking shows more generally (Mitchell & 
Waldby 2010), is that if information gathered through questionnaires, for example, does not exist already, 
it must be gathered alongside biological material, with new instruments created if necessary. The production 
of novel mundane technologies, that is, may be crucial to biotechnological enterprise.  
 Endophenotypes and the need for novel diagnostics 
In order to grasp the importance of questionnaires in contemporary understandings of autism it is crucial 
to recognize that studies in genomics are frequently based not upon clinical phenotypes but, instead, 
endophenotypes (Losh & Piven 2007: 105). Endophenotypes are so called ´intermediate phenotypesµ that 
are:  
...a heritable phenotypic feature that is closely related to a disorder but represents a more narrow 
or simple component than the disorder itself. An endophenotype should be observed in first-
degree relatives more frequently than in the general population and might be quantitative rather 
than binary. (Geschwind 2011: 409) 
Autism endophenotypes thus differ from the clinical phenotype in important ways. The clinical autism 
phenotype consists of ´persistent deficits in social communication and social interaction,µ and ´restricted, 
repetitive patterns of behavior, interests, or activitiesµ (American Psychiatric Association 2013: 50). 
Although framed as a dyad in DSM-5, this phenotype is historically referred to as the ´autism triadµ; it is 
the co-occurrence of the three symptom clusters (in social functioning, communication and restricted 
interests) that demonstrates a clinical phenotype. An endophenotype, however, may apply to just one of 
these domains (e.g. symptoms related to social functioning but not communication or restricted interests). 
Furthermore, behaviors associated with the endophenotype may be less pronounced than those associated 
with the clinical phenotype. Thus, an endophenotype relating to impaired communication may present itself 
in a dislike of social chitchat (Baron-Cohen et al. 2001) rather than a clinical ´ mindblindnessµ (Baron-Cohen 
1995).2 In the case of autism, those with endophenotypes are often said to exhibit the ´broader autism 
phenotypeµ 
There are two sound reasons for researchers working in genomics to focus upon endophenotypes, both 
relating to the issue of statistical power. First, core assumptions of genomic science are that autism is both 
heritable and arises as a result of multiple genes interacting. If this is the case then family members below 
the clinical cut-off for autism will both share some susceptibility genes for autism and present lesser 
symptoms of the sort described above. It would thus be an error to include family members in an 
undifferentiated non-clinical control group, because family members who ´are just below [clinical] cutoff 
may, in fact, share several genetic risk factors but would be classified as unaffected, so some information is 
lostµ with the result that the effects of these genes are obscured (Duvall et al. 2007: 658-659). Second, 
because it is believed that genetic studies will reveal numerous genetic sub-groups and that ´ common autism 
gene variants are likely to be of weak effect,µ genomic analyses will ´typically require very large sample sizes 
in order to have sufficient powerµ to detect candidate gene variants (Sucksmith et al. 2011: 382). In practical 
                                                          
2 There are a number of assumptions built into this model, for example that dislike of social chitchat and an inability 
to understand others thoughts and intentions (mindblindness) differ quantitatively rather than qualitatively. 
terms, therefore, being able to include individuals who do not have clinically diagnosable autism, but who 
do share autism gene variants, in a study design is exceptionally useful.  
It is these two important points²²the need to make significant use of the non-clinical population and the 
requirement that very large sample sizes are used²²that has necessitated the turn to endophenotypes. 
MSSNG, ´..a groundbreaking collaboration between Google and Autism Speaks [which seeks] to create the 
ZRUOG·V ODUJHVW JHQRPLF GDWDEDVH RQ DXWLVPµ (Autism Speaks,n.d.) is, for instance, archetypical of 
contemporary endophenotypic studies: A collection of 10,000 DNA samples representing trillions of data 
points from both individuals with a diagnosis and their families. MSSNG is far from being alone in seeking 
a model of this sort (Silverman 2012: 157-160; Singh 2016: 46-53).  
Despite utilizing cutting edge genomic and computer technologies, however, studies like MSSNG remain 
absolutely dependent upon behavioral observations; a biomarker must be correlated against a behavior in 
order for its effect to become apparent (Abend 2017). Langlitz has explored this issue in relation to 
neuroscientific investigations of consciousness: 
The investigation of neural correlates of consciousness and subjectively experienced mental 
events... requires that test subjects provide first-person accounts of their experiences. Otherwise, 
it would be impossible to tell what the measured neural correlates were correlates of. (Langlitz 
2010: 43, references removed) 
The same situation applies in autism genomics: In order to be understood, genotypes must be correlated 
against behavioral (endo)phenotypes. As an example, Alarcón et al. (2002) explore the underpinnings of 
social communication by examining correlations between genetic markers and behavioral criteria like ´age 
at first wordµ Without an observable, behavioral measure of social communication (such as age at first 
word) the effect of particular gene variants cannot be interpreted. To this end, studies like MSSNG²²where 
truly vast numbers of people are donating data and a good number of those people do not exhibit a clinical 
phenotype²²quickly encounter a problem with existing diagnostic procedures used to gather behavioral 
data, and they do so for at least three reasons.  
First, clinical examinations take too long, and are too expensive, to be practical with extremely large samples. 
For example, the Autism Diagnosis Observation Schedule (Lord et al. 1989; Lord et al. 2000), or ADOS, 
is often described as the ´gold standardµ diagnostic instrument within both clinical and research settings 
(Fombonne 2009: 592; Norbury & Sparks 2013: 7) and would be an obvious tool to gather the behavioral 
data required to interpret genomic analyses. An ADOS session takes around 40 minutes to complete and 
requires two highly trained observers who attend and re-watch and discuss diagnostic sessions (Hollin & 
Pilnick 2018). Such a process is simply too time- and resource-intensive for many of the studies imagined 
within genomics, which require huge sample sizes.  
Second, endophenotypes are assumed to be both quantifiable (i.e., exist in lesser variants) and apply to a 
narrow sub-component of the clinical phenotype (e.g. social communication but not social functioning or 
restricted interests). Thus, and as noted above, while an individual with the clinical autism phenotype may 
demonstrate both mindblindness (an LQDELOLW\WRGHWHUPLQHRWKHUV·LQWHQWLRQVDQGUHVWULFWHGLQWHUHVWVDQ
individual on the endophenotype may simply dislike social chitchat. Thus, diagnostic tools need to be able 
to both quantify DQLQGLYLGXDO·V´degree of autisticnessµ and examine the possible existence of diverse sub-
groups. Clinical methods such as the ADOS, however, were intended to provide little more than a yes/no 
qualitative diagnosis. Thus, while some quantification is possible with existing diagnostics (Lord et al. 2001), 
they are not ideal even when resource intensity is not an issue.3  
Finally, third, clinical tools like the ADOS are simply not sensitive enough to locate endophenotypes: There 
are almost certainly ´ceiling effectsµ (Constantino & Todd 2003: 529) in traditional diagnostics whereby 
many exhibiting an endophenotype would simply pass the test and score zero. For example, those who 
simply dislike social chitchat would, over the course of the ADOS, almost certainly still establish enough 
rapport with the examiner that they would be deemed to have no communication impairment. This would 
lead to individuals exhibiting endophenotypes being labeled ´unaffectedµ and the effect of genes obscured.  
For these three reasons, the turn to endophenotypes within a system oriented towards the goal of 
understanding autism in genomic terms rendered existing diagnostic techniques problematic. Importantly, 
these problems are both technical²²the need for instruments with increased sensitivity and the ability to 
                                                          
3 While it will always be time-intensive to collect data via a tool such as the ADOS, resources may be less of an 
issue, for example, because data is being collated from numerous collection sites. 
provide quantitative measures²²and economic; the huge numbers of people imagined necessary for 
genomic analyses necessitating a need for instruments to reveal phenotypes at a greatly reduced cost.  
Genomic science: A technological system with a reverse salient 
And this is where we start to move away from a narrow focus upon chromosomal microarrays and 
computing power. For while there is undoubtedly truth in assertions that these novel pieces of machinery 
are essential for ongoing genomics research, what the above discussion makes clear is that these tools could 
QRW EH XVHG HIIHFWLYHO\ ZLWKRXW DGGLWLRQDO PXQGDQH LQQRYDWLRQV 7KH VWRU\ RI DXWLVP·V FRQWHPSRUDU\
configurations can only be told if we include technologies that were intended to overcome the 
aforementioned limitations of existing diagnostics and designed to be cheap, easy, and quantitative. These 
technologies, in short, are questionnaires and surveys. 
We can understand the importance of questionnaires within contemporary genomics by utilizing the work 
of historian of technology Thomas Hughes (e.g. Hughes 1987)+XJKHV· work details processes of change 
within ´large technological systemsµ (LTS), a concept that has much in common with Michel &DOORQ·V
technoscientific ´actor-worldsµ (Callon 1981: 23).4 Indeed, by working through the cases examined by 
Hughes and Callon²²(GLVRQ·V VXFFHVVIXO ´HOHFWULILFDWLRQ LQ:HVWHUQ VRFLHW\µ LQ WKH FDVHRI WKH IRUPHU
(Hughes 1983) DQG(OHFWULFLWLpGH)UDQFH·V(')IDLOHGSURPRWLRQRIWKHYpKLFXOHpOHFWULTXH9(/LQWKH
case of the latter (Callon 1981)²²the core features of LTS can be discerned. 
First, LTS must be understood broadly and taken to include both material and semiotic features (Hughes 
1987: 51). The material-discursive nature of technological systems is made clear in both the case of Edison 
wherein the network included ´SK\VLFDODUWHIDFWVPLQHVPDQXIDFWXULQJILUPVXWLOLW\FRPSDQLHVDFDGHPLF
UHVHDUFKDQGGHYHORSPHQWODERUDWRULHVDQGLQYHVWPHQWEDQNVµ(Hughes 1986: 287) and in the case of the 
VEL where consumers, social movements, ministries, accumulators, fuel cells, electrodes, electrons, 
                                                          
4 Sovacool and colleagues identify a difference in ´focusµ rather than any overarching claim, to be the distinguishing 
difference between scholars who have followed an LTS approach and those like Callon embedded in Actor Network 
Theory (2018: 7). Here I emphasize WKH VLPLODULWLHV DQG WUHDW WKHPERWK DV H[DPSOHVRI ´WHFKQRORJ\-in-SUDFWLFHµ
(Timmermans & Berg 2003: 103). See Hughes (1986: 287-290) for a discussion on the points of similarity between 
´networksµ and ´systemsµ and Sovacool & Hess (2017) for a useful overview of frameworks detailing technological 
change and infrastructure. 
catalysts, and electrolytes are all crucial (Callon 1981: 22). These heterogeneous elements form a single LTS 
that cuts across analytic categories such as scientific, technical, legal, economic, social, and political.  
Second, heterogeneous elements must be understood as being co-constituted within DV\VWHP´GHVLJQHGWR
LQWHUDFWKDUPRQLRXVO\ZLWKWKHFKDUDFWHULVWLFVRIWKHRWKHUVµ+XJKHV&DOORQPDNHVWKLVSRLQW
clearlyVWDWLQJWKDWRQFH´«an actor-world comes into being, it does not draw entities from previously 
established stock. It is not constituted in the way a shopping cart is filledµ (1981: 24). The example of car 
manufacturer Renault, an imagined element within the LTS oriented towards the production of the VEL, 
makes this clear. AWWKHWLPHRI(')·VLQWHUYHQWLRQ, 5HQDXOWZDV´DSRZHUIXOFRPSDQ\WKDWVHHNVWREHWKH
ODUJHVW(XURSHDQFDUPDQXIDFWXUHUµ&DOORQ:LWKLQWKHHPHUJLQJLTS, however, Renault was 
reduced to little moUHWKDQ´DPRGHVWHQWLW\WKDWLQWHUYHQHVLQWKHDVVHPEO\RIWKH9(/µby providing car 
chassis (Callon 1981: 22-23). ´Renaultµ thus changes character considerably and ORVHV LWV ´FDWHJRULFDO
LQWHJULW\µ+XJKHV: the ´Renaultµ of the LTS oriented towards the VEL is quite different to the 
´Renaultµ in previously established stock.   
Third, components in an LTS are not only mutually-constitutive but also mutually-dependent. Such 
dependency ensures that if one component in a system is: 
«UHPRYHGIURPDV\VWHPRULILWVFKDUDFWHULVWLFVFKDQJHWKHRWKHUDUWLIDFWVLQWKHV\VWHPZLOODOWHU
characteristics accordingly. In an electric light and power system, for instance, a change in 
resistance, or load, in the system will bring compensatory changes in transmission, distribution, 
and generation of components. (Hughes 1987: 51) 
If compensation cannot be achieved then complete system break down may be experienced (Callon 1981: 
23).  
+XJKHVGHYHORSHGWKHFRQFHSWRIWKH´UHYHUVHVDOLHQWµ in order to better understand responses to system 
breakdown, lag, or friction: 
A salient is a protrusion in a geometric figure, a line of battle, or an expanding weather front. 
Reverse salients are components in the system that have fallen behind or are out of phase with the 
others. (Hughes 1987: 73) 
0DF.HQ]LHDQG:DMFPDQH[SDQGLQJXSRQWKH+XJKHV·GHILQLWLRQVLPLODUO\GUDZDWWHQWLRQWRWKHWHUP·V
military usage:  
 The reverse salient is a product of uneven development. It is an area where the growth of 
technology is seen as lagging, like a military front line which has been pushed forward but where 
in one particular spot the enemy holds out. Technologists focus inventive effort, like generals focus 
their forces, on the elimination of such reverse salients; a successful inventor defines the reverse 
salient as a set of ´critical problemsµ that, when solved, will correct the situation. (MacKenzie and 
Wajcman 1999: 17) 
Given that reverse salients have wide reaching effects, posing a problem for the whole system, it is perhaps 
unsurprising that, as suggestHG E\ 0DF.HQ]LH DQG :DMFPDQ ´FRPPXQLWLHV RI LQYHQWRUV FRQJUHJDWH DW
UHYHUVHVDOLHQWVLWHVµ (Hughes 1987: 74) attempting to address the situation and allow development to 
continue. 
If, as previously discussed, we consider it a common system goal of contemporary autism research to 
understand the condition in genomic terms then I suggest that we can readily understand clinical diagnostics 
as representing a reverse salient within this system. As discussed above, behavioral diagnostics continue to 
play a crucial role within contemporary bioscience (cf. Abend 2017; Langlitz 2010) and are thus an essential 
part of the LTS. For both the technical and economic reasons outlined above, however, clinical procedures 
such as the ADOS represent a significant lag within the system.  
As discussed above, Hughes suggests that when such a lag becomes evident within a community we should 
see a gathering of inventors seeking to address the problem. In the following section I will argue that just 
such a gathering occurred in the first years of the twenty-first century, with numerous research groups 
creating questionnaires designed to correct the reverse salient caused by clinical diagnostics. This 
observation, I suggest, demonstrates the importance of questionnaires to contemporary genomics research, 
the entanglement of emerging and mundane technologies in contemporary autism science, and the 
significant continuities between this contemporary system and past understandings. 
Questionnaires: Addressing the reverse salient 
The first decade of the twenty-first century saw numerous questionnaires published that attempted to 
address the reverse salient in diagnostics detailed above. These questionnaires included the Autism-
Spectrum Quotient (AQ; Baron-Cohen et al. 2001), the Broader Autism Phenotype Questionnaire (BAPQ; 
Hurley et al. 2007), the Social Responsiveness Scale (SRS; Constantino & Gruber 2007) WKH&KLOGUHQ·V
Communication Checklist (CCC; Bishop et al. 2006), and the Subthreshold Autism Trait Questionnaire 
(SATQ; Kanne et al. 2012).5 Scientists well recognized the importance of these questionnaires to ongoing 
genomic inquiries and instruments were either immediately used as part of genomic investigations or were 
explicitly positioned as being of utility to such projects. In this section I will detail the core characteristics 
RIWKHVHTXHVWLRQQDLUHVDQGVKRZWKDWWKH\HDFKVRXJKWWRDGGUHVVWKHNH\IHDWXUHVRIJHQRPLFVFLHQFH·V
reverse salient by addressing issues of affordability, sensitivity, and quantification. As three of the most 
widely used measures, my focus here is particularly upon the AQ, the BAPQ, and the SRS, although 
conclusions are applicable more widely.6 
As noted above, genomic analyses are increasingly understood as requiring very large sample sizes 
(Abrahams & Geschwind 2008: 350) and yet remain reliant upon behavioral diagnostics. Existing diagnostic 
technologies that take a lengthy period of time to conduct are costly in terms of time and money, posing 
problems of affordability. This issue of affordability was an explicit justification for the creation of the 
scales under consideration here (e.g. Hurley et al. 2007: 1688). In developing the AQ, for example, Baron-
Cohen and colleagues note that ´[e]xisting instruments, such as the ADI-R (Autism Diagnostic Interview), 
[and] the ADOS-G (Autism Diagnostic Observation Schedule) are fairly time-consuming to administer...µ 
                                                          
5 In addition to these questionnaires, Lord et al. (2001) suggested that the ADOS, outlined above, was a suitable 
instrument for quantification and Dawson et al. (2007) SURGXFHGWKH´%URDGHU3KHQRW\SH$XWLVP6\PSWRP6caleµ 
or BPASS. Like the ADOS, the BPASS requires extensive observation and interview by trained clinicians. Both of 
these papers were explicitly targeted at quantifying autism for the purpose of genetic analysis (Dawson et al. 2007: 
524; Lord et al. 2001: 36) and can be understood as attempts to address the same reverse salient as detailed above. 
Nonetheless, there has been a (relative) lack of uptake of these instruments, at least in the context considered here. I 
suggest this lack of uptake is due to the fact that while the BPASS seeks to address issues of sensitivity and 
quantification, the continued reliance upon trained clinicians means that economic issues are not addressed and, thus, 
the reverse salient remains.  
6 The research groups that developed these questionnaires²²such as Simon Baron-&RKHQ·V DW 7KH 8QLYHUVLW\ RI
CambriGJHDQG-RKQ&RQVWDQLQR·VDW7KH:DVKLQJWRQ8QLYHUVLW\6FKRRORI0HGLFLQHLQ6W/RXLV²²frequently were 
involved in both the development of questionnaires and the undertaking of genomic analyses. Thus, as was the case in 
+XJKHV·KLVWRULFDODQDO\VHV´V\VWHPEXLOGHUVZHUHQRUHVSHFWHUVRINQRZOHGJHFDWHJRULHVRUSURIHVVLRQDOERXQGDULHVµ 
(Hughes 1986: 285). The lack of attention paid to questionnaires is a feature of the social scientific literature on 
genomics, not the scientific literature itself.  
(Baron-Cohen et al. 2001: 6). Constantino and colleagues, discussing the SRS, note the particular problem 
that lengthy diagnostics cause for large scale projects typical of genomic analyses: ´[the] ADI-R takes 
upwards of two hours to complete, and this has limited its feasibility in clinical settings and in large 
population-based studiesµ (Constantino et al 2003: 428).7 
The construction of questionnaires like the AQ and the SRS addresses this economic lag. These 
questionnaires all consist of written questions that are answered on likert scales. As an example, question 1 
on the AQ is ´I prefer to do things with others rather than on my own,µ to which one responds ´definitely 
disagreeµ ´slightly disagreeµ ´slightly agreeµ or ´definitely agreeµ (Baron-Cohen et al. 2001: 15).   In case 
of the ADOS there are 50 questions that are answered on the above 4-point scale, in the case of BAPQ 
there are 36 questions entered on 6-point scale, and in the case of the SRS there are 65 questions rated on 
a 4-point scale. The SRS, comfortably the longest of these questionnaires, still only takes 15-20 minutes to 
complete (Constantino et al. 2003: 428). Such measures, thus, greatly reduced the amount of time required 
to procure diagnostic information needed for genomic analyses. And yet, the drive to shortening the 
diagnostic process continues: various short-form versions of both the AQ and SRS have been created that 
consist of 28, 20, and 10 questions in the case of the AQ and 30 and 11 questions in the case of the SRS 
(for details see Nishiyama et al. 2014: 996).  
These instruments also reduce the reliance upon highly trained clinicians or researchers who would 
previously be needed to administer interviews or observations and who are, of course, expensive to train 
and employ. The AQ and the BAPQ are both self-administered and, while the SRS was originally devised 
to be completed by teachers or parents (Constantino et al. 2004: 720), a self-administered version of the 
SRS has more recently been produced (Constantino & Cruber 2012). Completion of questionnaires, 
                                                          
7 While questionnaires are sometimes used as screening tools the ADI and the ADOS remain core instruments for 
clinical diagnoses. These quotations do, however, also demonstrate that whether these questionnaires are primarily 
oriented towards an investigation of the cause or the diagnosis of autism is not a straightforward matter. Those 
involved with the development of the AQ, for example, ´«ZLVKWRXQGHUOLQHWKDWWKH$4LVQRWDGLDJQRVWLFµ whilst 
also asserting its utility in ´distinguishing individuals who have clinically significant levels of autistic traitsµ(Baron-
Cohen et al. 2001: 14, 15). Researchers developing the SRS describe it as ´«DQHIIHFWLYHVXUURJDWHIRUWKHGLDJQRVLV
of autism in linkage studiesµ(Duvall et al. 2007: 657). What these passages remind us, and this is as true for social 
scientific analyses as the scientific work itself, is that epistemology and ontology in psychiatric diagnoses are mutually 
constitutive and it is hard to examine one without the other (Pickersgill 2011) 6HH %RQQLH (YDQV· ZRUN The 
Metamorphosis of Autism (Evans 2017) for further discussion in relation to autism. 
therefore, requires no expert guidance and measures can be, and often are, completed away from the clinic 
or online (e.g. Hoekstra et al. 2011).  Furthermore, questionnaire scores simply need to be tallied and, thus, 
results are unambiguous, require minimal interpretation, and further reduce the need for trained experts. In 
sum, addressing an economic lag by making the procurement of diagnostic information affordable with an 
LTS dependent upon behavioral data from huge numbers of people was a central rationale behind the 
emergence of these short-form questionnaires. 
If the economic issue of affordability is important to genomic analyses, the issues of sensitivity and 
quantification are of crucial technical importance. As noted above, for reasons of statistical power it is 
increasingly seen as important that endophenotypes²²sub-clinical behaviors regularly exhibited by genetic 
relatives of those diagnosed with autism²²come under examination (Duvall et al. 2007: 658; Losh et al. 
2009: 519). As discussed above, however, existing diagnostics are generally perceived as insufficiently 
sensitive to capture endophenotypes with ceiling effects ensuring that important endophenotypic data are 
lost. Those developing novel questionnaires stress that avoiding such ceiling effects must be a priority 
(Baron-Cohen & Wheelwright 2004: 167; Wheelwright et al. 2010: 2). Similar traits to those examined on 
the ADOS, therefore, are examined in the questionnaires though questions that are designed to be more 
sensitive to subtle impairments, such as ´>S@HRSOH DVNPH WR UHSHDW WKLQJV ,·YH VDLGEHFDXVH WKH\GRQ·W
understand, 1 [very rarely] - 6 [very often]µ (BAPQ; Hurley et al. 2007: 1688) and ´I frequently find that I 
GRQ·WNQRZKRZWRNHHSDFRQYHUVDWLRQJRLQJGHILQLWHO\DJUHH - definitely disagreeµ (AQ; Baron-Cohen et 
al. 2001: 15). 
Closely allied to this issue of sensitivity is that of quantification; it is important for genomic analyses that 
questionnaires are able to identify not only those exhibiting endophenotypes but also locate both clinical 
and non-clinical individuals within a normally distributed population (Wheelwright et al. 2010: 2) and, 
potentially, within a particular subgroup, so that genes associated with a particular symptom cluster may be 
identified. That these questionnaires are able to perform such tasks is described as their ´major advantageµ 
over existing diagnostics: 
The major advantage of the Social Responsiveness Scale [over the ADI] is that it measures these 
highly heritable characteristics on a quantitative scale, rather than relying on the qualitative 
diagnosis of autism. (Duvall et al. 2007: 657) 
The ´quantitative scaleµ for the SRS is an individual score between 0 and 175²²a normally distributed 
´autism spectrumµ (Sucksmith et al. 2011: 361) that extends throughout the general population. The AQ is 
scored similarly, with individuals placed on a continuous distribution of between 0-50 or 50-200 depending 
upon the variant being used (Hoekstra et al. 2008: 1565). The BAPQ, meanwhile, takes a different approach 
to quantification with mean scores (between 1 ² 6) presented. Additionally, authors in all cases emphasize 
that questionnaires can be used to tease apart various endophenotypes relating to particular behaviors, thus 
GHPRQVWUDWLQJ WKHLU FDSDFLW\ WR FRUUHFW WKH ´FULWLFDO SUREOHPµ 0DF.HQ]LH DQG :DMFPDQ   of 
existing diagnostics. 
To reiterate: despite the wide range of uses found for these questionnaires (see below) they were explicitly 
pitched as discriminative instruments (Nishiyama et al. 2014: 994) for use in genomics. John Constantino, 
co-creator of the SRS, is a practicing geneticist who immediately employed his own scales (e.g. Duvall et al. 
2007). Hurley et al., in their paper first detailing the BAPQ, conclude by stating that:  
The BAPQ is likely to find numerous uses in the increasing number of studies aimed at 
characterizing the milder expression of the genetic liability for autism in non-autistic relatives of 
autistic individuals. (Hurley et al. 2007: 1688) 
In relation to the AQ, Bishop states that: 
Compared with other methods of identifying the broad phenotype, the AQ has the advantage of 
being extremely quick and easy to administer, which means it has considerable potential for use in 
genetic studies that would benefit from a means of rapid phenotyping of large samples of 
individuals. (Bishop et al 2004: 1432) 
$QGLWLVQRWMXVWLQWKHDXWKRUV· own work that these questionnaires are used to undergird genomic analyses. 
These scales are standard measures for the largest genomic collections in the world, such as the Autism 
Simplex Collection (Buxbaum et al. 2014) and the Simons Simplex Collection (Fischbach & Lord 20108; 
see Singh (2014) for more on this collection programme). These questionnaires are, in short, key 
components of the LTS facilitating a genomic autism.  
Discussion and Conclusion: Mobile technologies 
In the previous sections I have detailed the importance of questionnaires to ongoing research in autism 
genomics, suggesting that numerous questionnaires were developed in the first years of the twenty-first 
century in order to address a crucial ´reverse salientµ in genomics that arose because of issues with the 
affordability, sensitivity, and quantifiability of existing diagnostics. Without these newly developed 
questionnaires, I have argued, it would have been much harder for genomic science to progress.  
This account is, in part, intended to complement or correct those narratives that focus exclusively upon 
genetic sequencing and extraordinary computing power when discussing biotechnology generally and 
emerging technologies in psychiatry specifically. I have argued that these undeniably important advances 
need to be understood as part of a much broader technological system (Hughes 1987). A failure to consider 
extensive systems risks a ´reheated futurismµ (Edgerton 2008) of which STS accounts of biomedicine have 
previously been accused (Kerr 2004; Michael 2003; Raman & Tutton 2010), a disservice to the scale and 
mechanisms of innovation, and under appreciating the entanglements of the exotic and the mundane 
(Michael 2003). 
This corrective is not the only, or even main, reason why social scientists should continue to foreground 
questionnaires, however. MacKenzie and Pardo-Garcia state that innovations involve the: 
...re-use of existing resources (ideas and other cultural resources as well as artefacts), not the 
mechanical implementation of a grand plan nor simply logical deduction from existing scientific 
theory...the making of devices involves putting together, retuning and refashioning systems. 
(MacKenzie & Pablo Pardo-Guerra 2014: 157)  
                                                          
8 Full collection details for the Simons Collection available from: https://sfari.org/resources/autism-
cohorts/simons-simplex-collection/ssc-instruments 
MacKenzie and Pardo-*DUFLD·V analysis here hints at the existence of what Edgerton has called ´¶creole· 
technologies, technologies transplanted from their place of origin finding uses on a greater scale elsewhereµ 
(Edgerton 2008: xiv). The AQ, perhaps the most culturally significant of the questionnaires considered 
here, has proven to be a highly mobile, creole technology par excellence, and it has done far more than simply 
facilitate genomic research. To give a flavor of this influence: First, the AQ has been translated into 
numerous languages²²including Chinese, Dutch, French, Italian, Japanese, Persian, and Polish (Ruzich et 
al., 2015: 10)²²allowing the AQ to become embedded in practice around the globe. Second, the self-
administered nature of AQ ensures that people can pick up these questionnaires themselves and use them 
as they see fit, operating outside of scientific institutions (see Murphy (2006: 143) for more on the diverse 
uses of questionnaires). Thus, the AQ has contributed to the wave of popular cultural attention that autism 
has attracted, due to being included in the pages of Wired Magazine (Silberman 2001) where readers were 
invited to ´take the testµ Meanwhile the UK television program Embarrassing Bodies hosts an online ´Mind 
Checkerµ that includes an online version of the AQ, which has been taken over 1.5 million times as of 
August 2017 (Channel 4 2014). Third, the AQ has been adopted in scientific communities operating at quite 
some distance to genomics. Jobe and Williams White (2007), for example, attempt to understand the nature 
RIVWXGHQWV·UHODWLRQVKLSVDQd the loneliness that some of those students experience, through the language 
of autism. As the work of Hughes and Callon might suggest, these researchers did no pick up the AQ as if 
IURPD´ZHOO-VWRFNHGVXSHUPDUNHWµ&DOORQEXWLQVWHDGWRUTXHG it for novel ends. In this context 
the AQ is not deployed to reveal something about autism genomics, but to examine personality traits that 
influence ´.the enjoyment of close friendships, loneliness, friendship quality, and negative interactions 
within a friendshipµ (Wainer et al. 2013: 2420). What these examples illustrate is that, while the AQ must 
be understood as being entangled with genomics, it KDVQRLQKHUHQW´FDWHJRULFDOLQWHJULW\µ+XJKHV
289) and cannot be reduced to it. Nor can we understand the AQ simply as a tool undergirding genomic 
research, for this is to miss a myriad of uses that warp and transform the AQ in different settings.  
A crucial task awaiting those researching the sciences of autism²²and for those who wish to understand 
LTS within contemporary biomedicine²²is to trace these technologies in full, beyond the laboratory and 
into the field where scientists cede both exclusive access and a significant degree of control (Lorimer 2015: 
102). This is not just an epistemically important task, but also an ethical one. Edgerton has argued that a 
consequence of focusing upon mundane technologies like, I would argue, questionnaires is that ´«ZHVKLIW
attention from the new to the old, the big to the small, the spectacular to the mundane, the masculine to 
the feminine, the rich to the poorµ (Edgerton 2008: xiv). Whereas accounts of geneticization, 
genomicization, and molecularization have been accused of universalizing ´a form of biopolitics within 
globalization that is specific to the zone of ¶liberal peace· in the affluent spaces of the westµ (Braun 2007: 
25), an examination of questionnaires and their ilk reminds us that that biotechnical knowledge extends far 
beyond the walls of the life sciences department (Raman & Tutton 2010: 721) or genetic clinic. Any attempt 
to understand the impact of emerging technologies on biomedicine, psychiatry, or autism, and which seeks 
to be ´genuinely globalµ (Edgerton 2008: xiii), must conceptualize technology more broadly. 
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